D E Merkel|C K Osborne - JoVE Visualize

Showing results (111-120 of 184) with videos related to

Pageof 19

Sort By:

Breast Cancer Research and Treatment|March 5, 1999

Time-dependence of hazard ratios for prognostic factors in primary breast cancerS G Hilsenbeck, P M Ravdin, C A de Moor, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 1998

Survival advantage of adjuvant chemotherapy in high-risk node-negative breast cancer: ten-year analysis--an intergroup studyE G Mansour, R Gray, A H Shatila, et al.

Investigational New Drugs|January 1, 1985

A randomized trial of doxorubicin, mitoxantrone and bisantrene in advanced breast cancer (a South West Oncology Group Study)J D Cowan, C K Osborne, J A Neidhart, et al.

Cancer Research|July 1, 1992

Inhibition of breast cancer cell growth in vitro by a tyrosine kinase inhibitorK B Reddy, G L Mangold, A K Tandon, et al.

Journal of the National Cancer Institute|March 10, 1999

Statistical analysis of array expression data as applied to the problem of tamoxifen resistanceS G Hilsenbeck, W E Friedrichs, R Schiff, et al.

Science (New York, N.Y.)|September 23, 1983

Tumor-derived growth factor increases bone resorption in a tumor associated with humoral hypercalcemia of malignancyK J Ibbotson, S M D'Souza, K W Ng, et al.

British Journal of Cancer|February 24, 2001

High rates of loss of heterozygosity on chromosome 19p13 in human breast cancerS Oesterreich, D C Allredl, S K Mohsin, et al.

Cancer Research|January 4, 1998

Mitosin (a new proliferation marker) correlates with clinical outcome in node-negative breast cancerG M Clark, D C Allred, S G Hilsenbeck, et al.

The Journal of Biological Chemistry|April 10, 1999

Binding of CtIP to the BRCT repeats of BRCA1 involved in the transcription regulation of p21 is disrupted upon DNA damageS Li, P L Chen, T Subramanian, et al.

Molecular Endocrinology (Baltimore, Md.)|May 13, 1999

Enhancement of insulin-like growth factor signaling in human breast cancer: estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivoA V Lee, J G Jackson, J L Gooch, et al.

Pageof 19

Showing results (111-120 of 184) with videos related to

Sort By:

Pageof 19

Breast Cancer Research and Treatment|March 5, 1999

Time-dependence of hazard ratios for prognostic factors in primary breast cancerS G Hilsenbeck, P M Ravdin, C A de Moor, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 1998

Survival advantage of adjuvant chemotherapy in high-risk node-negative breast cancer: ten-year analysis--an intergroup studyE G Mansour, R Gray, A H Shatila, et al.

Investigational New Drugs|January 1, 1985

A randomized trial of doxorubicin, mitoxantrone and bisantrene in advanced breast cancer (a South West Oncology Group Study)J D Cowan, C K Osborne, J A Neidhart, et al.

Cancer Research|July 1, 1992

Inhibition of breast cancer cell growth in vitro by a tyrosine kinase inhibitorK B Reddy, G L Mangold, A K Tandon, et al.

Journal of the National Cancer Institute|March 10, 1999

Statistical analysis of array expression data as applied to the problem of tamoxifen resistanceS G Hilsenbeck, W E Friedrichs, R Schiff, et al.

Science (New York, N.Y.)|September 23, 1983

Tumor-derived growth factor increases bone resorption in a tumor associated with humoral hypercalcemia of malignancyK J Ibbotson, S M D'Souza, K W Ng, et al.

British Journal of Cancer|February 24, 2001

High rates of loss of heterozygosity on chromosome 19p13 in human breast cancerS Oesterreich, D C Allredl, S K Mohsin, et al.

Cancer Research|January 4, 1998

Mitosin (a new proliferation marker) correlates with clinical outcome in node-negative breast cancerG M Clark, D C Allred, S G Hilsenbeck, et al.

The Journal of Biological Chemistry|April 10, 1999

Binding of CtIP to the BRCT repeats of BRCA1 involved in the transcription regulation of p21 is disrupted upon DNA damageS Li, P L Chen, T Subramanian, et al.

Molecular Endocrinology (Baltimore, Md.)|May 13, 1999

Enhancement of insulin-like growth factor signaling in human breast cancer: estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivoA V Lee, J G Jackson, J L Gooch, et al.

Pageof 19